E-LIB Suche - Ergebnisse für: Fasching, P

1

54P Real-world data of patients with recurrent BRCA-mutated..:

Marmé, F. ; Hilpert, F. ; Welslau, M.K....
ESMO Open. 9 (2024) - p. 103561 , 2024

Link: https://doi.org/10.1016/..

2

196P Surgical axillary intervention after neoadjuvant syste..:

Warnecke, F. ; Schneeweiss, A. ; Fasching, P.A....
ESMO Open. 9 (2024) - p. 103218 , 2024

Link: https://doi.org/10.1016/..

3

LBA1 Denosumab added to 2 different nab-paclitaxel regimens..:

Loibl, S. ; Reinisch, M. ; Just, M....
ESMO Open. 9 (2024) - p. 103478 , 2024

Link: https://doi.org/10.1016/..

4

Neoadjuvant pembrolizumab or placebo + chemotherapy, follow..:

Cardoso, F. ; O'Shaughnessy, J. ; McArthur, H....
European Journal of Cancer. 200 (2024) - p. 113608 , 2024

Link: https://doi.org/10.1016/..

5

216P What is driving treatment decision following 1st line ..:

Lüftner, D.I. ; Brucker, C. ; Dawkins, L.S.M....
ESMO Open. 9 (2024) - p. 103238 , 2024

Link: https://doi.org/10.1016/..

6

Long-term outcomes of a randomized, open-label, phase II st..:

Meyer-Wilmes, P. ; Huober, J. ; Untch, M....
ESMO Open. 9 (2024) 5 - p. 103009 , 2024

Link: https://doi.org/10.1016/..

7

Patient-reported outcomes and hospitalization data in patie..:

Curigliano, G. ; Dunton, K. ; Rosenlund, M....
Annals of Oncology. 34 (2023) 7 - p. 569-577 , 2023

Link: https://doi.org/10.1016/..

8

129P Impact of TROP-2 and its cellular localization on prog..:

Westhoff, C. ; Müller, S.K. ; Schmatloch, S....
ESMO Open. 8 (2023) 1 - p. 101468 , 2023

Link: https://doi.org/10.1016/..

9

203P Clinical effectiveness of olaparib in BRCA-mutated, HE..:

Gelmon, K.A. ; Fasching, P.A. ; Delaloge, S....
ESMO Open. 8 (2023) 1 - p. 101392 , 2023

Link: https://doi.org/10.1016/..

10

222P Real-world clinical outcomes among patients (pts) with..:

Hall, P.S. ; Chang, L. ; Parikh, R....
ESMO Open. 8 (2023) 1 - p. 101411 , 2023

Link: https://doi.org/10.1016/..

11

P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + ..:

Kümmel, S. ; Schmid, P. ; Harbeck, N....
The Breast. 68 (2023) - p. S63-S64 , 2023

Link: https://doi.org/10.1016/..

12

Updated overall survival from the MONALEESA-3 trial in post..:

Neven, P. ; Fasching, P. A. ; Chia, S....
Breast Cancer Research. 25 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

13

32O 5-year (y) overall survival (OS) with maintenance olapa..:

Lorusso, D. ; Mouret-Reynier, M-A. ; Harter, P....
ESMO Open. 8 (2023) 1 - p. 100812 , 2023

Link: https://doi.org/10.1016/..

14

Significantly longer time to deterioration of quality of li..:

Harbeck, N. ; Fasching, P.A. ; Wuerstlein, R....
Annals of Oncology. 34 (2023) 8 - p. 660-669 , 2023

Link: https://doi.org/10.1016/..

15

99P Exploratory analysis of differential gene expression (D..:

Denkert, C. ; Nowicka, M. ; Basik, M....
ESMO Open. 8 (2023) 1 - p. 101323 , 2023

Link: https://doi.org/10.1016/..